טוען...
Discovery of potent and selective butyrylcholinesterase inhibitors through the use of pharmacophore-based screening
Cholinesterase inhibitors have long been used in the treatment of Alzheimer’s Disease (AD) via the protection of acetylcholine levels. However, recent research has shown that the specific inhibition of butyrylcholinesterase (BChE) could better ameliorate symptoms within patients. In addition, it has...
שמור ב:
| הוצא לאור ב: | Bioorg Med Chem Lett |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6953623/ https://ncbi.nlm.nih.gov/pubmed/31708262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2019.126754 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|